18th Oct 2010 15:50
Amphion Innovations plc
Directors' Dealings Directors Receive Shares in Lieu of Fees
London and New York, 18 October 2010 - Amphion Innovations plc (the "Company")(LSE: AMP), the developer of medical and technology businesses, today announces that, at a Board meeting held on 13 October 2010, the Company has issued 249,820 ordinary shares, representing 0.19% of the enlarged issued share capital, to certain of its Board members, as their directors' fees for the second and third quarters to 30 September 2010, priced at 9.10p, being the average of the closing mid-market price for the five days leading up to the market close on 30 September 2010. Following this issue, the directors' shareholdings in the Company are as follows:
|
Director |
Number of New Shares |
Total Shareholding |
Percentage of voting rights |
|
|
|
|
|
|
R. James Macaleer |
149,820 |
22,740,912 |
17.12% |
|
Gerard Moufflet |
100,000 |
300,000 |
0.23% |
Director, Anthony Henfrey waived his fees for the second and third quarters 2010.
Admission of the 249,820 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 22 October 2010. Following this allotment the total issued share capital of the Company will increase to 133,498,743 ordinary shares with each share holding one voting right.
For further information please contact:
Amphion Innovations
Charlie Morgan:
+1 212 210-6224
Charles Stanley Securities, Nominated Advisor
Mark Taylor:
+44 020 7149 6000
Cardew Group
Tim Robertson/ Jamie Milton
+44 020 7930 0777
Related Shares:
AMP.L